Hydrogen and health / Research review
Hydrogen and lungs exposed to dust: smog, pneumoconiosis, interstitial lung disease
Three randomised trials concern people whose lungs are burdened by dust or fibrosis. After a month of inhalation, workers exposed to smog coughed less, and in silicosis the authors observed a better diffusing capacity of the lungs when hydrogen was added to treatment.
Covers
Studies
Human studies: 3 studies in the cards below, including 3 randomised.
How hydrogen was given
Inhalation, hydrogen water.
On this page
Smog and pneumoconiosis: key findings from the studies
- Workers exposed to polluted air: after 30 days of inhalation, less coughing, lower inflammatory markers and slightly higher FEV₁.
- Silicosis (108 people): better diffusing capacity of the lungs and less breathlessness with hydrogen added to the medicine.
- Early interstitial lung disease: improvement on CT in 73.0% of people who completed 48 weeks of drinking hydrogen water versus 39.5% in the comparison group.
Hydrogen and smog: a study of workers exposed to polluted air
96 municipal service workers breathed a hydrogen-oxygen mixture or a nitrogen-oxygen mixture for an hour a day1. After 30 days the hydrogen group reported less coughing, had lower selected inflammatory markers and an FEV₁ of about 97% versus 95% of the predicted value. The clearest changes were in coughing and some of the inflammatory markers.
Hydrogen, pneumoconiosis and interstitial lung disease
In a study of 108 people with stage II silicosis, the authors observed a greater improvement in the diffusing capacity of the lungs and in breathlessness with hydrogen inhalation added to tetrandrine than with the medicine alone2. Here hydrogen was an add-on to the medicine.
In early interstitial lung disease, 48 weeks of drinking hydrogen water were compared with N-acetylcysteine3. Among the people who completed the study, 73.0% showed improvement on CT versus 39.5% (p=0.008).
Hydrogen and smog and pneumoconiosis: the studies we refer to
Click an entry to see who took part in the study, how hydrogen was given and what the result was.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Effects of smog exposure in municipal workers
randomised trialn = 96inhalation2016
Effects of smog exposure in municipal workers
- Participants
- Workers exposed to air pollution
- Protocol
- H2/O2 66.67%/33.33% vs N₂/O2, 1 h/day for 30 days
- Result
- Less coughing and lower selected inflammatory markers. On day 30, FEV₁ was about 97% vs 95% of the predicted value (p<0.05).
- Study context
- RCT, double-blind. Participants: 96.
Gong ZJ i wsp.. [Protective effect of hydrogen on the lung of sanitation workers exposed to haze]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 39(12): 916-923. 2016. PubMed 27938540 · DOI
2Stage II silicosis
randomised trialn = 108inhalation2026
Stage II silicosis
- Participants
- 116 enrolled; 54 H2 + tetrandrine and 54 tetrandrine alone in the analysis
- Protocol
- H2 as an addition to tetrandrine; comparison with the medicine alone
- Result
- The combination improved the diffusing capacity of the lungs and breathlessness; IL-6 was lower than with the medicine alone (p<0.05).
- Study context
- RCT, double-blind. Participants: 108.
Xiao K i wsp.. The clinical efficacy of hydrogen combined with tetrandrine in the treatment of silicosis fibrosis: A randomized controlled intervention study. Respiratory medicine 260: 108939. 2026. PubMed 42250702 · DOI
3Early interstitial lung disease
Hydrogen waterrandomised trialn = 872023
Early interstitial lung disease
- Participants
- 44 H2 and 43 NAC in the ITT analysis; 75 completed the protocol
- Protocol
- 350 ml of H2 at 1.6 ppm 2× a day for 48 weeks vs NAC
- Result
- More favourable CPI and DLCO. HRCT improvement: 63.6% vs 39.5% in the ITT analysis; among those completing the protocol 73.0% vs 39.5% (p=0.008).
- Study context
- Randomised controlled trial. Participants: 87.
Tang C i wsp.. Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial. Therapeutics and clinical risk management 19: 1051-1061. 2023. PubMed 38107500 · DOI · Full text
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
Smog and pneumoconiosis: topics in this area
Smog and pneumoconiosis and hydrogen: frequently asked questions
How was hydrogen given in the smog and pneumoconiosis studies?
Workers exposed to polluted air breathed a hydrogen-oxygen mixture for one hour a day for 30 days. In silicosis, inhalation was added to a medicine, and in early interstitial lung disease participants drank 350 ml of hydrogen water twice a day for 48 weeks.
What changed after a month of inhalation in people exposed to smog?
After 30 days the hydrogen group reported less coughing and had lower levels of selected inflammation markers. FEV₁ was about 97% of the predicted value, compared with 95% in the comparison group.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.